InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2022-05-02 00:00:00 ET · period of report 2022-04-29 · accession 0001062993-22-011167 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-02 2022-04-29 BIO RAMALINGAM AJIT SVP, CAO M - OptEx $0.00 +277 697.69 +66% $0
D 2022-05-02 2022-04-29 BIO RAMALINGAM AJIT SVP, CAO F - Tax $512.06 -96 601.69 -14% -$49.2K
D 2022-05-02 2022-04-29 BIO RAMALINGAM AJIT SVP, CAO M - OptEx $0.00 -277 831 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2022-04-29 M A 277 $0.00 697.69 D — — (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 12.1142, 5.1601, and 13.0147 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2021, 12/31/2021, and 03/31/2022, respectively.
2 Common Bio-Rad A Common Stock 2022-04-29 F D 96 $512.06 601.69 D — —
3 Derivative Restricted Stock Units 2022-04-29 M D 277 $0.00 831 D $0.00 · — to — 277 Bio-Rad A Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.